Literature DB >> 11084946

Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases.

M Cutolo1, R L Wilder.   

Abstract

It is now documented that androgens and estrogens modulate susceptibility and progression to autoimmune rheumatic diseases. At any concentration, androgens seem to be primarily suppressive on cellular and humoral immunity, whereas at physiologic concentrations, estrogens seem to enhance humoral immunity. Further research should focus on the different and frequently opposite effects exerted by physiologic and pharmacologic doses of estrogens (dose-related effects). In addition to the influence of endogenous estrogen fluctuations (i.e., during pregnancy, postpartum, menstrual periods, menopause), estrogen replacement therapy, and the use of oral contraceptives, the susceptibility to autoimmunity might be increased by the environmental estrogens (xenobiotics). Further studies must be directed to the inflammatory mediators (i.e., cytokines) that seem to alter the peripheral metabolism of sex hormones and complicate the effects of sex hormones on susceptibility to autoimmunity. Finally, genetic factors might further interfere with the roles of androgens and estrogens in selected individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11084946     DOI: 10.1016/s0889-857x(05)70171-x

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  37 in total

Review 1.  Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome.

Authors:  Roland Jonsson; Tom P Gordon; Yrjö T Konttinen
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

2.  Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats.

Authors:  Michaele B Manigrasso; R Taylor Sawyer; Zachary M Hutchens; Elizabeth R Flynn; Christine Maric-Bilkan
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

Review 3.  [Why are there analogous disease mechanisms in chronic inflammatory diseases?].

Authors:  Rainer H Straub; Hugo O Besedovsky; Adriana Del Rey
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Quantitative determination of steroid hormone receptor positive cells in the synovium of patients with rheumatoid arthritis and osteoarthritis: is there a link to inflammation?

Authors:  S Capellino; B Riepl; L Rauch; P Angele; M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2006-06-30       Impact factor: 19.103

Review 5.  Immune modulation by estrogens: role in CNS HIV-1 infection.

Authors:  Melinda E Wilson; Filomena O Dimayuga; Janelle L Reed; Thomas E Curry; Carol F Anderson; Avindra Nath; Annadora J Bruce-Keller
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

6.  Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.

Authors:  C J Malkin; P J Pugh; P D Morris; K E Kerry; R D Jones; T H Jones; K S Channer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

7.  Neuroimmune interaction in inflammatory diseases.

Authors:  Peyman Otmishi; Joshiah Gordon; Seraj El-Oshar; Huafeng Li; Juan Guardiola; Mohamed Saad; Mary Proctor; Jerry Yu
Journal:  Clin Med Circ Respirat Pulm Med       Date:  2008-04-29

Review 8.  Sex and gender in psychoneuroimmunology research: past, present and future.

Authors:  Beth D Darnall; Edward C Suarez
Journal:  Brain Behav Immun       Date:  2009-03-09       Impact factor: 7.217

9.  Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  P Härle; G Pongratz; C Weidler; R Büttner; J Schölmerich; R H Straub
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

10.  Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands?

Authors:  David A Sullivan; Roderick V Jensen; Tomo Suzuki; Stephen M Richards
Journal:  Mol Vis       Date:  2009-08-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.